Concepts (243)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heart Septal Defects, Ventricular | 3 | 2025 | 133 | 2.030 |
Why?
|
| Scimitar Syndrome | 3 | 2021 | 52 | 1.890 |
Why?
|
| Cardiac Surgical Procedures | 6 | 2025 | 1173 | 1.770 |
Why?
|
| Vascular Surgical Procedures | 6 | 2024 | 552 | 1.620 |
Why?
|
| Aortic Coarctation | 2 | 2024 | 105 | 1.430 |
Why?
|
| Heart Transplantation | 3 | 2024 | 877 | 1.430 |
Why?
|
| Tetralogy of Fallot | 3 | 2022 | 176 | 1.390 |
Why?
|
| Androgen Receptor Antagonists | 3 | 2025 | 41 | 1.370 |
Why?
|
| Prostatic Neoplasms, Castration-Resistant | 2 | 2025 | 94 | 1.070 |
Why?
|
| Aortic Valve Insufficiency | 2 | 2020 | 158 | 1.060 |
Why?
|
| Aorta, Thoracic | 4 | 2024 | 540 | 0.990 |
Why?
|
| Bundle of His | 1 | 2025 | 10 | 0.930 |
Why?
|
| Cystectomy | 2 | 2025 | 165 | 0.920 |
Why?
|
| Postoperative Complications | 5 | 2021 | 3139 | 0.910 |
Why?
|
| Peritoneal Neoplasms | 1 | 2025 | 57 | 0.870 |
Why?
|
| Lower Urinary Tract Symptoms | 1 | 2024 | 40 | 0.820 |
Why?
|
| Independent Living | 1 | 2024 | 70 | 0.810 |
Why?
|
| Urinary Bladder Neoplasms | 2 | 2025 | 540 | 0.810 |
Why?
|
| Incidental Findings | 1 | 2024 | 129 | 0.800 |
Why?
|
| Acute Kidney Injury | 2 | 2020 | 671 | 0.770 |
Why?
|
| Fontan Procedure | 2 | 2022 | 186 | 0.760 |
Why?
|
| Pulmonary Veins | 2 | 2021 | 172 | 0.760 |
Why?
|
| Embolism, Air | 1 | 2022 | 24 | 0.760 |
Why?
|
| Heart Septal Defects | 1 | 2022 | 44 | 0.750 |
Why?
|
| Sutureless Surgical Procedures | 1 | 2021 | 7 | 0.730 |
Why?
|
| Replantation | 2 | 2022 | 56 | 0.730 |
Why?
|
| Pulmonary Artery | 3 | 2022 | 456 | 0.730 |
Why?
|
| Pulmonary Veno-Occlusive Disease | 1 | 2021 | 28 | 0.720 |
Why?
|
| Frailty | 1 | 2024 | 136 | 0.700 |
Why?
|
| Blood Vessel Prosthesis Implantation | 3 | 2018 | 787 | 0.690 |
Why?
|
| Myosin Heavy Chains | 1 | 2021 | 70 | 0.690 |
Why?
|
| Robotic Surgical Procedures | 1 | 2025 | 222 | 0.680 |
Why?
|
| Loeys-Dietz Syndrome | 1 | 2021 | 42 | 0.660 |
Why?
|
| Coronary Stenosis | 1 | 2021 | 83 | 0.650 |
Why?
|
| Coronary Vessel Anomalies | 1 | 2024 | 290 | 0.640 |
Why?
|
| Lipocalin-2 | 1 | 2019 | 32 | 0.640 |
Why?
|
| Fatty Acid-Binding Proteins | 1 | 2019 | 34 | 0.630 |
Why?
|
| Heart Rate | 5 | 2018 | 584 | 0.620 |
Why?
|
| Aortic Aneurysm, Thoracic | 2 | 2018 | 704 | 0.610 |
Why?
|
| Japan | 4 | 2025 | 156 | 0.610 |
Why?
|
| Heart Valve Diseases | 2 | 2020 | 178 | 0.610 |
Why?
|
| Coronary Vessels | 3 | 2024 | 548 | 0.600 |
Why?
|
| Aortic Diseases | 1 | 2021 | 196 | 0.600 |
Why?
|
| Heart Defects, Congenital | 2 | 2022 | 1861 | 0.590 |
Why?
|
| Humans | 37 | 2025 | 131924 | 0.590 |
Why?
|
| Tachycardia, Ectopic Junctional | 1 | 2018 | 13 | 0.580 |
Why?
|
| Pericardium | 1 | 2019 | 92 | 0.580 |
Why?
|
| Aorta | 2 | 2021 | 550 | 0.570 |
Why?
|
| Morpholines | 1 | 2018 | 67 | 0.570 |
Why?
|
| Aortic Aneurysm | 1 | 2021 | 237 | 0.560 |
Why?
|
| Therapeutic Irrigation | 1 | 2018 | 45 | 0.560 |
Why?
|
| Arterial Switch Operation | 1 | 2018 | 24 | 0.550 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2021 | 376 | 0.550 |
Why?
|
| Organ Sparing Treatments | 1 | 2018 | 43 | 0.550 |
Why?
|
| Urea | 1 | 2018 | 230 | 0.540 |
Why?
|
| Esophageal Stenosis | 1 | 2017 | 46 | 0.520 |
Why?
|
| Echocardiography | 5 | 2024 | 1128 | 0.520 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2018 | 224 | 0.520 |
Why?
|
| Heart Valves | 1 | 2017 | 53 | 0.520 |
Why?
|
| Carotid Artery, Common | 1 | 2017 | 66 | 0.520 |
Why?
|
| Blood Vessel Prosthesis | 2 | 2018 | 515 | 0.520 |
Why?
|
| Deglutition | 1 | 2017 | 60 | 0.510 |
Why?
|
| Infant | 9 | 2024 | 13047 | 0.510 |
Why?
|
| Coronary Aneurysm | 1 | 2016 | 33 | 0.500 |
Why?
|
| Thrombosis | 1 | 2021 | 524 | 0.500 |
Why?
|
| Drainage | 1 | 2018 | 262 | 0.500 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2021 | 2166 | 0.490 |
Why?
|
| Male | 28 | 2025 | 64870 | 0.490 |
Why?
|
| Aortic Rupture | 1 | 2017 | 119 | 0.480 |
Why?
|
| Hematoma | 1 | 2016 | 92 | 0.480 |
Why?
|
| Prosthesis-Related Infections | 1 | 2018 | 187 | 0.470 |
Why?
|
| DNA | 1 | 2021 | 1472 | 0.460 |
Why?
|
| Deglutition Disorders | 1 | 2017 | 145 | 0.460 |
Why?
|
| Cardiopulmonary Resuscitation | 1 | 2019 | 332 | 0.450 |
Why?
|
| Coronary Angiography | 1 | 2016 | 485 | 0.420 |
Why?
|
| Treatment Outcome | 8 | 2025 | 12991 | 0.420 |
Why?
|
| Heart Valve Prosthesis Implantation | 1 | 2018 | 458 | 0.400 |
Why?
|
| Aged | 10 | 2025 | 21385 | 0.390 |
Why?
|
| Endovascular Procedures | 2 | 2018 | 785 | 0.370 |
Why?
|
| Mutation | 3 | 2023 | 6226 | 0.370 |
Why?
|
| Extracorporeal Membrane Oxygenation | 1 | 2019 | 654 | 0.370 |
Why?
|
| Azotobacter vinelandii | 1 | 2011 | 1 | 0.360 |
Why?
|
| Molybdenum | 1 | 2011 | 12 | 0.360 |
Why?
|
| Siderophores | 1 | 2011 | 10 | 0.360 |
Why?
|
| Heart | 5 | 2022 | 689 | 0.360 |
Why?
|
| Multigene Family | 1 | 2011 | 305 | 0.330 |
Why?
|
| Aged, 80 and over | 5 | 2025 | 7097 | 0.320 |
Why?
|
| Retrospective Studies | 8 | 2025 | 17374 | 0.320 |
Why?
|
| Alkynes | 3 | 2006 | 29 | 0.310 |
Why?
|
| Time Factors | 4 | 2024 | 6440 | 0.300 |
Why?
|
| Middle Aged | 9 | 2025 | 28943 | 0.300 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2025 | 1127 | 0.290 |
Why?
|
| Adenosine | 3 | 2006 | 135 | 0.290 |
Why?
|
| Child, Preschool | 5 | 2024 | 14732 | 0.280 |
Why?
|
| Female | 20 | 2025 | 70584 | 0.280 |
Why?
|
| Heart Conduction System | 3 | 2025 | 159 | 0.260 |
Why?
|
| Child | 6 | 2024 | 25761 | 0.260 |
Why?
|
| Urinary Bladder | 2 | 2025 | 254 | 0.260 |
Why?
|
| Neoplasm Invasiveness | 2 | 2025 | 663 | 0.250 |
Why?
|
| Coronary Circulation | 5 | 2006 | 206 | 0.240 |
Why?
|
| Receptors, Androgen | 2 | 2025 | 409 | 0.230 |
Why?
|
| Computed Tomography Angiography | 2 | 2017 | 215 | 0.230 |
Why?
|
| Ki-67 Antigen | 1 | 2025 | 112 | 0.230 |
Why?
|
| Infant, Newborn | 4 | 2024 | 8542 | 0.230 |
Why?
|
| Anilides | 1 | 2024 | 58 | 0.220 |
Why?
|
| B7-H1 Antigen | 1 | 2025 | 125 | 0.210 |
Why?
|
| Xerostomia | 1 | 2024 | 12 | 0.210 |
Why?
|
| Nitriles | 1 | 2024 | 154 | 0.210 |
Why?
|
| Abnormalities, Multiple | 2 | 2019 | 981 | 0.190 |
Why?
|
| Bundle-Branch Block | 1 | 2022 | 38 | 0.180 |
Why?
|
| Anastomosis, Surgical | 1 | 2022 | 167 | 0.180 |
Why?
|
| Sutures | 1 | 2022 | 69 | 0.180 |
Why?
|
| Perfusion | 1 | 2022 | 208 | 0.180 |
Why?
|
| Pulmonary Circulation | 1 | 2021 | 117 | 0.170 |
Why?
|
| Mitral Valve | 2 | 2020 | 268 | 0.170 |
Why?
|
| Severity of Illness Index | 2 | 2021 | 3087 | 0.170 |
Why?
|
| Blood Pressure | 4 | 2018 | 1400 | 0.170 |
Why?
|
| Biomarkers | 3 | 2020 | 3404 | 0.170 |
Why?
|
| Suture Techniques | 1 | 2022 | 189 | 0.170 |
Why?
|
| Prostheses and Implants | 1 | 2022 | 152 | 0.170 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2025 | 808 | 0.170 |
Why?
|
| Device Removal | 1 | 2022 | 225 | 0.170 |
Why?
|
| Tissue Donors | 1 | 2024 | 504 | 0.170 |
Why?
|
| Glyburide | 4 | 1999 | 23 | 0.160 |
Why?
|
| Lipocalins | 1 | 2019 | 35 | 0.160 |
Why?
|
| Heart Atria | 1 | 2022 | 340 | 0.160 |
Why?
|
| Purinergic P1 Receptor Agonists | 1 | 1999 | 5 | 0.160 |
Why?
|
| Cerebrovascular Circulation | 1 | 2022 | 476 | 0.150 |
Why?
|
| Risk Factors | 3 | 2025 | 10933 | 0.150 |
Why?
|
| Organ Size | 1 | 2020 | 447 | 0.150 |
Why?
|
| Pulmonary Atresia | 1 | 2019 | 49 | 0.150 |
Why?
|
| DNA Mutational Analysis | 1 | 2021 | 824 | 0.150 |
Why?
|
| Myocarditis | 1 | 2020 | 132 | 0.150 |
Why?
|
| Postoperative Period | 1 | 2019 | 334 | 0.150 |
Why?
|
| Transplantation, Autologous | 1 | 2019 | 286 | 0.150 |
Why?
|
| Prognosis | 2 | 2025 | 5007 | 0.150 |
Why?
|
| Reoperation | 1 | 2021 | 851 | 0.140 |
Why?
|
| Mitral Valve Insufficiency | 1 | 2020 | 185 | 0.140 |
Why?
|
| Dilatation, Pathologic | 1 | 2018 | 89 | 0.140 |
Why?
|
| ROC Curve | 1 | 2019 | 600 | 0.140 |
Why?
|
| Renal Dialysis | 1 | 2025 | 947 | 0.140 |
Why?
|
| Creatinine | 1 | 2019 | 412 | 0.140 |
Why?
|
| Aneurysm, Ruptured | 1 | 1998 | 35 | 0.140 |
Why?
|
| Thoracoscopy | 1 | 2018 | 43 | 0.140 |
Why?
|
| Debridement | 1 | 2018 | 92 | 0.140 |
Why?
|
| Ductus Arteriosus, Patent | 1 | 2019 | 144 | 0.130 |
Why?
|
| Cricoid Cartilage | 1 | 2017 | 16 | 0.130 |
Why?
|
| Incidence | 1 | 2025 | 3375 | 0.130 |
Why?
|
| Duodenum | 1 | 1998 | 113 | 0.130 |
Why?
|
| Kidney Failure, Chronic | 1 | 2025 | 950 | 0.130 |
Why?
|
| Pancreas | 1 | 1998 | 222 | 0.130 |
Why?
|
| Aortography | 1 | 2017 | 183 | 0.130 |
Why?
|
| Conservative Treatment | 1 | 2016 | 41 | 0.130 |
Why?
|
| Genetic Testing | 1 | 2023 | 1098 | 0.120 |
Why?
|
| Needles | 1 | 2016 | 53 | 0.120 |
Why?
|
| Prostatic Neoplasms | 1 | 2024 | 1576 | 0.120 |
Why?
|
| Embolization, Therapeutic | 1 | 1998 | 223 | 0.120 |
Why?
|
| Echocardiography, Transesophageal | 1 | 2016 | 258 | 0.120 |
Why?
|
| Hypoplastic Left Heart Syndrome | 1 | 2018 | 271 | 0.110 |
Why?
|
| Cross-Sectional Studies | 1 | 2024 | 3760 | 0.110 |
Why?
|
| Potassium Channels | 3 | 1994 | 160 | 0.110 |
Why?
|
| Dogs | 7 | 2006 | 652 | 0.110 |
Why?
|
| Foreign Bodies | 1 | 2016 | 110 | 0.110 |
Why?
|
| Intensive Care Units, Pediatric | 1 | 2018 | 466 | 0.110 |
Why?
|
| Follow-Up Studies | 1 | 2024 | 5408 | 0.110 |
Why?
|
| Adolescent | 3 | 2024 | 20535 | 0.110 |
Why?
|
| Calcium Channel Blockers | 2 | 1990 | 118 | 0.100 |
Why?
|
| Cardiovascular Diseases | 1 | 2025 | 2091 | 0.090 |
Why?
|
| Receptors, Purinergic | 1 | 1992 | 14 | 0.090 |
Why?
|
| Catechols | 1 | 2011 | 9 | 0.090 |
Why?
|
| Stents | 1 | 2018 | 868 | 0.090 |
Why?
|
| Guanidines | 2 | 2001 | 23 | 0.090 |
Why?
|
| Culture Media | 1 | 2011 | 183 | 0.090 |
Why?
|
| Genes, Bacterial | 1 | 2011 | 217 | 0.080 |
Why?
|
| Gene Targeting | 1 | 2011 | 173 | 0.080 |
Why?
|
| Thiazoles | 1 | 1990 | 100 | 0.080 |
Why?
|
| Age Factors | 1 | 2017 | 2912 | 0.080 |
Why?
|
| Pyridines | 2 | 2001 | 249 | 0.080 |
Why?
|
| Anti-Arrhythmia Agents | 2 | 2001 | 223 | 0.080 |
Why?
|
| Iron | 1 | 2011 | 302 | 0.070 |
Why?
|
| Peptides | 1 | 2011 | 846 | 0.070 |
Why?
|
| Cardiotonic Agents | 2 | 2006 | 136 | 0.070 |
Why?
|
| Myocardial Contraction | 3 | 1999 | 255 | 0.060 |
Why?
|
| Anti-Bacterial Agents | 1 | 2018 | 2554 | 0.060 |
Why?
|
| Myocardial Infarction | 2 | 2006 | 1046 | 0.060 |
Why?
|
| Vasodilator Agents | 2 | 1999 | 207 | 0.060 |
Why?
|
| Reperfusion Injury | 1 | 2006 | 110 | 0.060 |
Why?
|
| Androstenes | 1 | 2024 | 7 | 0.060 |
Why?
|
| Thiohydantoins | 1 | 2024 | 4 | 0.060 |
Why?
|
| Phenylthiohydantoin | 1 | 2024 | 15 | 0.060 |
Why?
|
| Tosyl Compounds | 1 | 2024 | 24 | 0.060 |
Why?
|
| Flutamide | 1 | 2024 | 27 | 0.060 |
Why?
|
| Prostate-Specific Antigen | 1 | 2025 | 271 | 0.050 |
Why?
|
| Benzamides | 1 | 2024 | 124 | 0.050 |
Why?
|
| Sodium-Hydrogen Exchangers | 2 | 2001 | 30 | 0.050 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2025 | 392 | 0.050 |
Why?
|
| Androgen Antagonists | 1 | 2024 | 133 | 0.050 |
Why?
|
| Neoadjuvant Therapy | 1 | 2025 | 391 | 0.050 |
Why?
|
| Niacinamide | 2 | 1994 | 31 | 0.050 |
Why?
|
| Papillary Muscles | 2 | 1999 | 17 | 0.050 |
Why?
|
| Myocardial Stunning | 1 | 2001 | 19 | 0.040 |
Why?
|
| Health Care Costs | 1 | 2024 | 414 | 0.040 |
Why?
|
| Chordae Tendineae | 1 | 2020 | 7 | 0.040 |
Why?
|
| In Vitro Techniques | 2 | 1999 | 862 | 0.040 |
Why?
|
| Atrioventricular Node | 1 | 1999 | 15 | 0.040 |
Why?
|
| Myocardial Reperfusion Injury | 1 | 2000 | 129 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 1992 | 1672 | 0.040 |
Why?
|
| Potassium Channel Blockers | 1 | 1999 | 86 | 0.040 |
Why?
|
| Rupture, Spontaneous | 1 | 1998 | 47 | 0.040 |
Why?
|
| Blood Flow Velocity | 1 | 1999 | 439 | 0.030 |
Why?
|
| Myocardial Ischemia | 1 | 2000 | 342 | 0.030 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2000 | 481 | 0.030 |
Why?
|
| Catheterization | 1 | 1998 | 241 | 0.030 |
Why?
|
| Animals | 8 | 2006 | 34781 | 0.030 |
Why?
|
| Radiography | 1 | 1998 | 819 | 0.030 |
Why?
|
| Norepinephrine | 2 | 1992 | 166 | 0.030 |
Why?
|
| Hemodynamics | 2 | 2006 | 850 | 0.030 |
Why?
|
| Fever | 1 | 2016 | 310 | 0.030 |
Why?
|
| Signal Transduction | 1 | 2025 | 4703 | 0.020 |
Why?
|
| Inflammation | 1 | 2020 | 1519 | 0.020 |
Why?
|
| Theophylline | 1 | 1992 | 24 | 0.020 |
Why?
|
| Injections, Intravenous | 1 | 1992 | 247 | 0.020 |
Why?
|
| Injections, Intra-Arterial | 1 | 1990 | 18 | 0.020 |
Why?
|
| Benzopyrans | 1 | 1990 | 20 | 0.020 |
Why?
|
| Pyrroles | 1 | 1990 | 182 | 0.020 |
Why?
|
| Myocardium | 2 | 2006 | 906 | 0.020 |
Why?
|
| Receptors, Adenosine A2 | 1 | 2006 | 3 | 0.020 |
Why?
|
| Creatine Kinase | 1 | 2006 | 64 | 0.020 |
Why?
|
| Ischemic Preconditioning | 1 | 2006 | 22 | 0.020 |
Why?
|
| Necrosis | 1 | 2006 | 209 | 0.010 |
Why?
|
| Nicorandil | 2 | 1994 | 2 | 0.010 |
Why?
|
| Aconitine | 1 | 2000 | 9 | 0.010 |
Why?
|
| Sulfones | 1 | 2000 | 73 | 0.010 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2001 | 448 | 0.010 |
Why?
|
| Rats, Wistar | 1 | 2000 | 329 | 0.010 |
Why?
|
| Depression, Chemical | 1 | 1994 | 37 | 0.010 |
Why?
|
| Rats | 1 | 2000 | 3608 | 0.010 |
Why?
|
| Drug Interactions | 1 | 1994 | 246 | 0.010 |
Why?
|
| Cromakalim | 1 | 1990 | 1 | 0.010 |
Why?
|
| Diltiazem | 1 | 1990 | 14 | 0.010 |
Why?
|
| Nitroglycerin | 1 | 1990 | 23 | 0.010 |
Why?
|
| Anesthesia, Spinal | 1 | 1990 | 11 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2000 | 4680 | 0.000 |
Why?
|